Nu Skin Enterprises (NYSE:NUS) Raised to “Buy” at StockNews.com

Nu Skin Enterprises (NYSE:NUSGet Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Monday.

A number of other equities analysts have also commented on NUS. DA Davidson cut their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating for the company in a report on Monday, August 12th. Citigroup cut their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research note on Tuesday, October 22nd.

Read Our Latest Research Report on Nu Skin Enterprises

Nu Skin Enterprises Stock Up 0.1 %

NUS opened at $7.23 on Monday. Nu Skin Enterprises has a 12 month low of $5.95 and a 12 month high of $20.75. The company has a market cap of $359.35 million, a PE ratio of -3.46 and a beta of 1.14. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The company has a 50 day moving average of $6.82 and a 200 day moving average of $9.82.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Pacer Advisors Inc. purchased a new position in Nu Skin Enterprises during the second quarter worth about $25,230,000. Federated Hermes Inc. grew its holdings in shares of Nu Skin Enterprises by 111.8% during the second quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock worth $13,950,000 after purchasing an additional 698,722 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Nu Skin Enterprises by 4.4% in the first quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock worth $89,751,000 after purchasing an additional 274,309 shares during the last quarter. Millennium Management LLC raised its stake in Nu Skin Enterprises by 100.5% in the second quarter. Millennium Management LLC now owns 534,579 shares of the company’s stock valued at $5,634,000 after purchasing an additional 267,965 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its position in Nu Skin Enterprises by 178.3% during the first quarter. Jacobs Levy Equity Management Inc. now owns 283,355 shares of the company’s stock valued at $3,919,000 after purchasing an additional 181,528 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.